Publications

5674 Results

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study.

Authors
CR Nichols;PJ Catalano;ED Crawford;NJ Vogelzang;LH Einhorn;PJ Loehrer
Journal / Conference
Journal of Clinical Oncology 16(4):1287-1293
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8997 (EST-3887) (ECOG-3887)

Fluorouracil (FU), leucovorin (LV), and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089.

Authors
DG Haller;PJ Catalano;JS Macdonald;RJ Mayer
Journal / Conference
Proc of the American Society of Clinical Oncology 17:256a(#982)
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

Interpreting clinical trials 2: Factorial designs, subset analyses, and intent to treat.

Authors
J Crowley
Journal / Conference
American Society of Clinical Oncology Education Book :253-259
Year
1998

Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin(P) etoposide (E) and concurrent 45 GY thoracic radiotherapy (TRT) given in daily (QD) or twice-daily fractions followed by 25 GY PCI. Survival differencs and patterns of failure.

Authors
A Turrisi;K Kim;W Sause;R Komaki;H Wagner;S Aisner;R Livingston;R Blum;D Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:457a(#1757
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

Incidence and clinical significance of variant morphology (small cell/large cell subtype) in limited stage small cell lung cancer (SCLC). A prospective analysis of an intergroup ECOG, RTOG and SWOG study.

Authors
SC Aisner;A Turrisi;KM Kim;WT Sause;RB Livingston;L Einhorn;H Wagner;D Ettinger;R Komaki;R Blum;DH Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:458a(#1764)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

Phase II trial of etoposide (V), ifosfamide (I) plus cisplatin (P) in patients with advanced thymoma (T) or thymic carcinoma (TC): Preliminary results from an ECOG coordinated intergroup trial.

Authors
PJ Loehrer;M Jiroutek;S Aisner;J Aisner;MR Greene;CR Thomas Jr;RB Livingston;DH Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:30a(#118)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9449 (INT-0156) (E1C93)

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

Authors
DS Alberts;S Green;EV Hannigan;R O'Toole;D Stock-Novack;P Anderson;EA Surwit;VK Malvlya;WA Nahhas;CJ Jolles
Journal / Conference
Classic Papers and Current Comments 3(1):145-157
Year
1998
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial.

Authors
H Koops;M Vaglini;S Suciu;BBR Kroon;JF Thompson;J Gohl;AMM Eggermont;F Di Filippo;ET Krementz;D Ruiter;FJ Lejeune
Journal / Conference
Journal of Clinical Oncology 16(9):2906-2912
Year
1998
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8593 (INT-0065)

New REAL clinical entities.

Authors
RI Fisher;TP Miller;TM Grogan
Journal / Conference
Cancer Journal from Scientific American 4(Suppl.2):S5-S12
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Inadequate documentation and resection for gastric cancer in the United States: A preliminary report.

Authors
NC Estes;JS Macdonald;K Touijer;J Benedetti;J Jacobson
Journal / Conference
The American Surgeon 64(7):680-685
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)